(LHX) L3Harris Technologies - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5024311095
Stock: Satellites, Radios, Sensors, Missiles, Night Vision
Total Rating 61
Risk 87
Buy Signal 0.81
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.90% |
| Yield on Cost 5y | 3.57% |
| Yield CAGR 5y | 4.15% |
| Payout Consistency | 96.7% |
| Payout Ratio | 45.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 22.9% |
| Relative Tail Risk | -9.50% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.31 |
| Alpha | 63.53 |
| Character TTM | |
|---|---|
| Beta | 0.451 |
| Beta Downside | 0.315 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.98% |
| CAGR/Max DD | 0.79 |
Description: LHX L3Harris Technologies January 27, 2026
L3Harris Technologies (NYSE:LHX) delivers mission-critical solutions to government and commercial clients through three operating segments: Space & Mission Systems (SMS), which blends satellite, missile-warning, maritime and air special-mission capabilities; Communications & Spectrum Dominance (CSD), which supplies tactical radios, software waveforms, satellite terminals, broadband and integrated vision systems for U.S. and allied defense and public-safety customers; and Missile Solutions (MSL), which focuses on propulsion, hypersonic and advanced missile technologies.
Recent performance highlights include FY 2024 Q3 revenue of $3.22 billion, a 7% year-over-year increase driven primarily by higher demand for ISR (intelligence, surveillance, reconnaissance) payloads and C-band satellite terminals. The company reported a record backlog of roughly $30 billion, indicating strong order flow into 2025-2026. Macro-level, U.S. defense spending is projected to rise about 3% in FY 2025, bolstering demand for the high-growth hypersonic and communications segments that L3Harris leads.
For a deeper dive into valuation metrics and scenario analysis, consider reviewing L3Harris’s data on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 1.61b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.39 > 1.0 |
| NWC/Revenue: 6.25% < 20% (prev 2.74%; Δ 3.51% < -1%) |
| CFO/TA 0.08 > 3% & CFO 3.11b > Net Income 1.61b |
| Net Debt (9.37b) to EBITDA (3.57b): 2.62 < 3 |
| Current Ratio: 1.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (188.2m) vs 12m ago -1.26% < -2% |
| Gross Margin: 24.11% > 18% (prev 0.22%; Δ 2388 % > 0.5%) |
| Asset Turnover: 52.56% > 50% (prev 50.77%; Δ 1.79% > 0%) |
| Interest Coverage Ratio: 4.24 > 6 (EBITDA TTM 3.57b / Interest Expense TTM 597.0m) |
Altman Z'' 1.91
| A: 0.03 (Total Current Assets 8.59b - Total Current Liabilities 7.23b) / Total Assets 41.20b |
| B: 0.10 (Retained Earnings 4.17b / Total Assets 41.20b) |
| C: 0.06 (EBIT TTM 2.53b / Avg Total Assets 41.60b) |
| D: 0.91 (Book Value of Equity 19.64b / Total Liabilities 21.56b) |
| Altman-Z'' Score: 1.91 = BBB |
Beneish M -3.71
| DSRI: 0.29 (Receivables 1.37b/4.68b, Revenue 21.86b/21.32b) |
| GMI: 0.92 (GM 24.11% / 22.25%) |
| AQI: 0.99 (AQ_t 0.73 / AQ_t-1 0.74) |
| SGI: 1.03 (Revenue 21.86b / 21.32b) |
| TATA: -0.04 (NI 1.61b - CFO 3.11b) / TA 41.20b) |
| Beneish M-Score: -3.71 (Cap -4..+1) = AAA |
What is the price of LHX shares?
As of February 10, 2026, the stock is trading at USD 350.60 with a total of 811,291 shares traded.
Over the past week, the price has changed by +3.04%, over one month by +4.42%, over three months by +18.54% and over the past year by +71.43%.
Over the past week, the price has changed by +3.04%, over one month by +4.42%, over three months by +18.54% and over the past year by +71.43%.
Is LHX a buy, sell or hold?
L3Harris Technologies has received a consensus analysts rating of 4.32.
Therefore, it is recommended to buy LHX.
- StrongBuy: 14
- Buy: 5
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LHX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 380.6 | 8.6% |
| Analysts Target Price | 380.6 | 8.6% |
| ValueRay Target Price | 433.9 | 23.8% |
LHX Fundamental Data Overview February 09, 2026
P/E Trailing = 40.9918
P/E Forward = 28.169
P/S = 2.992
P/B = 3.331
P/EG = 2.0684
Revenue TTM = 21.86b USD
EBIT TTM = 2.53b USD
EBITDA TTM = 3.57b USD
Long Term Debt = 10.44b USD (from longTermDebt, last quarter)
Short Term Debt = 845.0m USD (from shortTermDebt, two quarters ago)
Debt = 10.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.37b USD (from netDebt column, last quarter)
Enterprise Value = 74.79b USD (65.42b + Debt 10.44b - CCE 1.07b)
Interest Coverage Ratio = 4.24 (Ebit TTM 2.53b / Interest Expense TTM 597.0m)
EV/FCF = 27.89x (Enterprise Value 74.79b / FCF TTM 2.68b)
FCF Yield = 3.59% (FCF TTM 2.68b / Enterprise Value 74.79b)
FCF Margin = 12.27% (FCF TTM 2.68b / Revenue TTM 21.86b)
Net Margin = 7.35% (Net Income TTM 1.61b / Revenue TTM 21.86b)
Gross Margin = 24.11% ((Revenue TTM 21.86b - Cost of Revenue TTM 16.59b) / Revenue TTM)
Gross Margin QoQ = 25.60% (prev 26.40%)
Tobins Q-Ratio = 1.82 (Enterprise Value 74.79b / Total Assets 41.20b)
Interest Expense / Debt = 1.37% (Interest Expense 143.0m / Debt 10.44b)
Taxrate = 21.47% (82.0m / 382.0m)
NOPAT = 1.99b (EBIT 2.53b * (1 - 21.47%))
Current Ratio = 1.19 (Total Current Assets 8.59b / Total Current Liabilities 7.23b)
Debt / Equity = 0.53 (Debt 10.44b / totalStockholderEquity, last quarter 19.64b)
Debt / EBITDA = 2.62 (Net Debt 9.37b / EBITDA 3.57b)
Debt / FCF = 3.50 (Net Debt 9.37b / FCF TTM 2.68b)
Total Stockholder Equity = 19.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.86% (Net Income 1.61b / Total Assets 41.20b)
RoE = 8.28% (Net Income TTM 1.61b / Total Stockholder Equity 19.39b)
RoCE = 8.48% (EBIT 2.53b / Capital Employed (Equity 19.39b + L.T.Debt 10.44b))
RoIC = 6.34% (NOPAT 1.99b / Invested Capital 31.34b)
WACC = 6.68% (E(65.42b)/V(75.86b) * Re(7.58%) + D(10.44b)/V(75.86b) * Rd(1.37%) * (1-Tc(0.21)))
Discount Rate = 7.58% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -0.63%
[DCF Debug] Terminal Value 83.69% ; FCFF base≈2.47b ; Y1≈2.59b ; Y5≈3.01b
Fair Price DCF = 328.5 (EV 70.83b - Net Debt 9.37b = Equity 61.45b / Shares 187.1m; r=6.68% [WACC]; 5y FCF grow 5.23% → 2.90% )
EPS Correlation: -45.99 | EPS CAGR: -2.29% | SUE: 1.09 | # QB: 4
Revenue Correlation: 93.74 | Revenue CAGR: 8.90% | SUE: -1.44 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.55 | Chg30d=-0.135 | Revisions Net=-3 | Analysts=14
EPS current Year (2026-12-31): EPS=11.67 | Chg30d=-0.748 | Revisions Net=-5 | Growth EPS=+8.8% | Growth Revenue=+7.1%
EPS next Year (2027-12-31): EPS=13.63 | Chg30d=-0.617 | Revisions Net=-2 | Growth EPS=+16.8% | Growth Revenue=+7.1%
P/E Forward = 28.169
P/S = 2.992
P/B = 3.331
P/EG = 2.0684
Revenue TTM = 21.86b USD
EBIT TTM = 2.53b USD
EBITDA TTM = 3.57b USD
Long Term Debt = 10.44b USD (from longTermDebt, last quarter)
Short Term Debt = 845.0m USD (from shortTermDebt, two quarters ago)
Debt = 10.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.37b USD (from netDebt column, last quarter)
Enterprise Value = 74.79b USD (65.42b + Debt 10.44b - CCE 1.07b)
Interest Coverage Ratio = 4.24 (Ebit TTM 2.53b / Interest Expense TTM 597.0m)
EV/FCF = 27.89x (Enterprise Value 74.79b / FCF TTM 2.68b)
FCF Yield = 3.59% (FCF TTM 2.68b / Enterprise Value 74.79b)
FCF Margin = 12.27% (FCF TTM 2.68b / Revenue TTM 21.86b)
Net Margin = 7.35% (Net Income TTM 1.61b / Revenue TTM 21.86b)
Gross Margin = 24.11% ((Revenue TTM 21.86b - Cost of Revenue TTM 16.59b) / Revenue TTM)
Gross Margin QoQ = 25.60% (prev 26.40%)
Tobins Q-Ratio = 1.82 (Enterprise Value 74.79b / Total Assets 41.20b)
Interest Expense / Debt = 1.37% (Interest Expense 143.0m / Debt 10.44b)
Taxrate = 21.47% (82.0m / 382.0m)
NOPAT = 1.99b (EBIT 2.53b * (1 - 21.47%))
Current Ratio = 1.19 (Total Current Assets 8.59b / Total Current Liabilities 7.23b)
Debt / Equity = 0.53 (Debt 10.44b / totalStockholderEquity, last quarter 19.64b)
Debt / EBITDA = 2.62 (Net Debt 9.37b / EBITDA 3.57b)
Debt / FCF = 3.50 (Net Debt 9.37b / FCF TTM 2.68b)
Total Stockholder Equity = 19.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.86% (Net Income 1.61b / Total Assets 41.20b)
RoE = 8.28% (Net Income TTM 1.61b / Total Stockholder Equity 19.39b)
RoCE = 8.48% (EBIT 2.53b / Capital Employed (Equity 19.39b + L.T.Debt 10.44b))
RoIC = 6.34% (NOPAT 1.99b / Invested Capital 31.34b)
WACC = 6.68% (E(65.42b)/V(75.86b) * Re(7.58%) + D(10.44b)/V(75.86b) * Rd(1.37%) * (1-Tc(0.21)))
Discount Rate = 7.58% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -0.63%
[DCF Debug] Terminal Value 83.69% ; FCFF base≈2.47b ; Y1≈2.59b ; Y5≈3.01b
Fair Price DCF = 328.5 (EV 70.83b - Net Debt 9.37b = Equity 61.45b / Shares 187.1m; r=6.68% [WACC]; 5y FCF grow 5.23% → 2.90% )
EPS Correlation: -45.99 | EPS CAGR: -2.29% | SUE: 1.09 | # QB: 4
Revenue Correlation: 93.74 | Revenue CAGR: 8.90% | SUE: -1.44 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.55 | Chg30d=-0.135 | Revisions Net=-3 | Analysts=14
EPS current Year (2026-12-31): EPS=11.67 | Chg30d=-0.748 | Revisions Net=-5 | Growth EPS=+8.8% | Growth Revenue=+7.1%
EPS next Year (2027-12-31): EPS=13.63 | Chg30d=-0.617 | Revisions Net=-2 | Growth EPS=+16.8% | Growth Revenue=+7.1%